PEPTIDE PREPARATION
Cerebrolysin
Cerebrolysin is a porcine brain-derived peptide preparation used for neurological indications in several countries. It is not FDA-approved i...
CATEGORY
This category includes compounds developed in several regulatory systems, with uneven clinical evidence and limited independent replication. Cerebrolysin has human clinical records. Dihexa remains preclinical. Semax, Selank, and Noopept require country-specific regulatory context.
Human trial or approved-indication records are available. Read each page for the exact scope and limits.
High. None of these are FDA-approved. Cerebrolysin is approved in 40+ countries but cannot be legally prescribed or sold in the United States. Semax and Selank are on the FDA bulk substance risk list. Noopept is sold as a dietary supplement despite being a registered pharmaceutical in Russia. Dihexa has no human safety or efficacy data whatsoever.
ALL COMPOUNDS